Retatrutide – 20mg (5 Pack)

Retatrutide is a cutting-edge triple-agonist peptide that activates GLP-1, GIP,
and glucagon receptors. This receptor synergy makes it a leading research compound
in obesity, glycemic control, and metabolic health studies.
The 5 pack of 20mg vials provides a total of 100mg, making it an excellent choice
for laboratories conducting long-term or large-scale experiments.

Potential Research Benefits

• Explored for weight reduction & appetite regulation
• Studied for glucose metabolism & insulin response
• Supports energy expenditure & lipid control
• Triple receptor activity: GLP-1, GIP & glucagon

Scientific Background

Retatrutide’s ability to activate GLP-1, GIP, and glucagon receptors sets it apart
from single- or dual-agonist peptides.
Research findings indicate enhanced metabolic outcomes such as weight loss,
improved glycemic control, and lipid regulation.
Its multi-pathway design has positioned it at the forefront of modern peptide-based
metabolic research.

Product Details

• Compound: Retatrutide
• Form: Lyophilized Powder
• Amount: 20mg per vial
• Pack Size: 5 vials (20mg each)
• Total Peptide: 100mg
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption